Want to see CLVT full AI Analyst Report?
CLVT Stock Chart & Stats
$2.03
$0.27(12.68%)
At close: 4:00 PM EDT
$2.03
$0.27(12.68%)
Day’s Range― - ―
52-Week Range$1.42 - $3.87
Previous Close$2.4
Volume9.18M
Average Volume (3M)4.20M
Market Cap
$1.14B
Enterprise Value$5.42B
Total Cash (Recent Filing)$217.70M
Total Debt (Recent Filing)$4.26B
Price to Earnings (P/E)―
Beta0.96
Next Earnings
Nov 03, 2026EPS Estimate
0.18Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.52
Shares Outstanding639,664,000
10 Day Avg. Volume3,389,876
30 Day Avg. Volume4,204,288
Financial Highlights & Ratios
PEG Ratio0.16
Price to Book (P/B)0.46
Price to Sales (P/S)0.92
P/FCF Ratio6.16
Enterprise Value/Market Cap4.76
Enterprise Value/Revenue2.25
Enterprise Value/Gross Profit3.36
Enterprise Value/Ebitda8.14
Forecast
1Y Price Target
$3.02Price Target Upside48.77% Upside
Rating ConsensusHold
Number of Analyst Covering5
EPS Forecast (FY)0.74
Revenue Forecast (FY)$2.31B
Bulls Say, Bears Say
Bulls Say
Strong Cash GenerationConsistently positive operating and free cash flow gives Clarivate internal funding for debt reduction, product investment, and customer initiatives. The TTM improvement strengthens financial flexibility, although year-to-year free cash flow volatility means execution remains important.
Margin Expansion And Recurring MixHigher margins and a greater recurring-revenue mix can make earnings more predictable and improve cash-flow visibility. Cost discipline and portfolio disposals support profitability, while the subscription-heavy model should reinforce retention and operating leverage over coming quarters.
AI Product TractionEarly customer adoption of AI-native research and IP products indicates Clarivate is extending its proprietary data and workflow advantages into higher-value offerings. Commercial traction can support cross-selling, strengthen differentiation, and create a durable growth avenue across core markets.
Bears Say
Persistent Revenue DeclineOngoing top-line contraction limits the company’s ability to expand earnings organically and suggests portfolio rationalization has not yet been fully replaced by core growth. Transactional weakness is offsetting subscription gains, increasing dependence on execution in A&G and IP.
Continued Net LossesPersistent bottom-line losses show that improved EBITDA and adjusted earnings have not yet translated into GAAP profitability. This weakens retained capital, limits balance-sheet quality, and leaves Clarivate more reliant on cash generation and restructuring progress to fund its strategy.
Meaningful Leverage And Negative ReturnsAlthough debt has declined, meaningful leverage combined with negative returns on equity constrains financial flexibility and indicates capital is not yet producing shareholder-level profitability. Debt reduction should help, but the balance sheet remains exposed to continued operating underperformance.
Clarivate News
CLVT FAQ
What was Clarivate’s price range in the past 12 months?
Clarivate lowest stock price was $1.42 and its highest was $3.87 in the past 12 months.
What is Clarivate’s market cap?
Clarivate’s market cap is $1.14B.
When is Clarivate’s upcoming earnings report date?
Clarivate’s upcoming earnings report date is Nov 03, 2026 which is in 12 days.
How were Clarivate’s earnings last quarter?
Clarivate released its earnings results on Jul 29, 2026. The company reported $0.19 earnings per share for the quarter, beating the consensus estimate of $0.181 by $0.009.
Is Clarivate overvalued?
According to Wall Street analysts Clarivate’s price is currently Undervalued.
Does Clarivate pay dividends?
Clarivate does not currently pay dividends.
What is Clarivate’s EPS estimate?
Clarivate’s EPS estimate is 0.18.
How many shares outstanding does Clarivate have?
Clarivate has 639,664,000 shares outstanding.
What happened to Clarivate’s price movement after its last earnings report?
Clarivate reported an EPS of $0.19 in its last earnings report, beating expectations of $0.181. Following the earnings report the stock price went down -10.417%.
Which hedge fund is a major shareholder of Clarivate?
Currently, no hedge funds are holding shares in CLVT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Clarivate Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$3.02 (48.77% Upside)
$3.02 (48.77% Upside)
Blogger Sentiment
Bullish
CLVT Sentiment 75%
Sector Average 65%
Sector Average 65%
Hedge Fund Trend
Decreased
By 182.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $3.2M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 1.0%
Last 30 Days ▼ 0.2%
Last 30 Days ▼ 0.2%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-51.91%
12-Months-Change
Fundamentals
Return on Equity
-7.00%
Trailing 12-Months
Asset Growth
-8.19%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Clarivate
Clarivate Plc operates as a prominent information services and analytics firm, furnishing structured data and insights. Its core mission is to facilitate the discovery, safeguard the intellectual property, and enable the commercialization of scientific research, innovations, and established brands. The company's portfolio includes the extensive Web of Science suite, a collection of essential tools such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio. These are designed to support organizations throughout the entire research lifecycle, from initial planning and funding to execution and utilization. Within the Life Sciences domain, Clarivate provides specialized products like Cortellis and Newport Integrity. These platforms cater to pharmaceutical and biotechnology companies, empowering their research endeavors, supplying vital market intelligence, and facilitating competitive monitoring during the development and launch phases of novel drugs. Its Derwent product line, comprising Derwent Innovation, Techstreet, and IP Professional Services, is dedicated to intellectual property management. These tools enable customers to evaluate the originality of potential products, establish their freedom to operate within design parameters, secure patent protection, analyze the competitive technological landscape, and ensure adherence to essential industry standards. Complementing these, CompuMark delivers trademark screening, search, and monitoring solutions vital for businesses and legal firms. Meanwhile, MarkMonitor empowers enterprises to establish, manage, optimize, and fortify their digital presence. Clarivate's diverse clientele spans government agencies, academic institutions, life science enterprises, and research and development corporations worldwide, with operations across the Americas, Middle East, Africa, Europe, and Asia Pacific regions. The company, initially known as Clarivate Analytics Plc, rebranded to Clarivate Plc in May 2020. It maintains its headquarters in London, United Kingdom.
CLVT Company Deck
CLVT Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call emphasized clear progress on strategic priorities—AI product launches with early commercial traction, margin expansion, debt reduction and a higher-quality recurring revenue mix driven by portfolio rationalization. These positives were tempered by near-term headwinds including a large non-cash impairment related to the LS&H divestiture, transactional revenue declines, one-time transaction costs that depress free cash flow this year, and FX impacts. Management presented a credible path to sequential organic growth and profitability improvement in the second half, with stronger recurring revenue mix and disciplined capital allocation supporting confidence in longer-term execution.View all CLVT earnings summariesCLVT Stock 12 Month Forecast
Average Price Target
$3.02
▲(48.77% Upside)
Technical Analysis
Ownership Overview
6.22% Insiders
8.60% Mutual Funds
11.23% Other Institutional Investors
63.94% Public Companies and
Individual Investors